Amylmetacresol

BRAND NAMES

• Strepsils – widely sold globally as a sore throat lozenge.

• Covonia – certain formulations for sore throat relief.

• Cepacol – in some regions, contains amylmetacresol alongside other antiseptics.

• Halls Defense / Halls Plus – select versions include amylmetacresol.

MECHANISM OF ACTION

Amylmetacresol is a topical antiseptic commonly used in throat lozenges to relieve sore throat and minor oral infections. Its mechanism of action involves disrupting the cell membranes of bacteria and some viruses in the oral cavity, reducing microbial load and limiting infection. This local antimicrobial effect helps alleviate irritation and inflammation, providing symptomatic relief from throat discomfort. Often combined with 2,4-dichlorobenzyl alcohol, Amylmetacresol works synergistically to enhance antiseptic activity, making it effective for short-term relief of sore throat symptoms without significant systemic absorption.

PHARMACOKINETICS

Absorption

Amylmetacresol is minimally absorbed when administered orally in lozenges or throat sprays. Its primary action is local, targeting the mucosa of the mouth and throat, and only a small fraction may be swallowed and absorbed into the bloodstream. This limited absorption contributes to its low systemic exposure and overall safety, making it suitable for short-term symptomatic relief of sore throat without significant systemic effects.

Distribution

Amylmetacresol has very limited systemic distribution due to its primarily local action in the oral cavity and pharynx. Because only a small amount is absorbed into the bloodstream, it does not reach significant concentrations in body tissues or organs. Its effects are largely confined to the site of administration, which minimizes systemic exposure and reduces the risk of systemic side effects.

Metabolism

Amylmetacresol undergoes minimal metabolism in the body. Since its absorption from the oral cavity is very low, the majority of the compound acts locally and only a small fraction that is swallowed may be metabolized in the liver. Most of the absorbed portion is likely conjugated or modified slightly before excretion, but systemic metabolism plays a minor role in its overall pharmacological effect.

Elimination

Amylmetacresol is mainly eliminated unchanged in the feces, as only a small fraction is absorbed systemically. Any absorbed portion undergoes minimal metabolism and is excreted in the urine. Its primary local action in the oral cavity means elimination is largely through gastrointestinal excretion, contributing to its low systemic toxicity and favorable safety profile.

PHARMACODYNAMICS

Amylmetacresol is a topical antiseptic that exerts its pharmacodynamic effects locally in the oral cavity and pharynx. It works by disrupting the cell membranes of bacteria and some viruses, reducing microbial load and limiting infection. This antimicrobial action alleviates irritation and inflammation, providing symptomatic relief of sore throat and minor oral infections. When combined with agents like 2,4-dichlorobenzyl alcohol, its antiseptic activity is enhanced, making it effective for short-term relief without significant systemic effects.

ADMINISTRATION

Amylmetacresol is administered orally, primarily in the form of lozenges, throat sprays, or pastilles. The lozenge is allowed to dissolve slowly in the mouth, releasing the antiseptic locally onto the throat and oral mucosa for maximum effect. It is intended for short-term symptomatic relief of sore throat and minor mouth infections, and the frequency of administration typically follows the instructions on the product label, usually every 2–3 hours as needed.

DOSAGE AND STRENGTH

Amylmetacresol is commonly formulated in lozenges or pastilles at a standard strength of 0.6 mg per lozenge, often combined with 2,4-dichlorobenzyl alcohol 1.2 mg for enhanced antiseptic effect. The typical adult and pediatric dosage is 1 lozenge every 2–3 hours as needed, with a usual maximum of 8–12 lozenges in 24 hours. It is intended for short-term symptomatic relief of sore throat and minor oral infections and should not be used for prolonged periods without medical advice.

DRUG INTERACTIONS

Amylmetacresol has minimal systemic absorption, so it rarely causes drug interactions. Its local action in the mouth and throat means it does not affect the metabolism or effectiveness of other medications. It can generally be used safely alongside other drugs, with no clinically significant interactions reported.

FOOD INTERACTIONS

Amylmetacresol has no significant food interactions because it acts locally in the throat with minimal systemic absorption. Eating or drinking immediately after using a lozenge may reduce its contact time on the mucosa, so it is best to allow the lozenge to dissolve completely for maximum effect.

CONTRAINDICATIONS

Amylmetacresol is contraindicated in individuals with a known hypersensitivity to amylmetacresol, 2,4-dichlorobenzyl alcohol, or any other ingredients in the formulation. It should not be used in patients with severe oral lesions or open wounds that may increase absorption, and caution is advised in young children due to the risk of choking on lozenges.

SIDE EFFECTS

Amylmetacresol is generally well tolerated, with most side effects being mild and local. Common reactions may include temporary oral irritation, burning sensation, or a slight numbness in the mouth and throat. Rarely, some individuals may experience allergic reactions such as rash, itching, or swelling. Systemic side effects are uncommon due to its minimal absorption.

TOXICITY

Amylmetacresol has a low toxicity profile because it is primarily active locally in the oral cavity with minimal systemic absorption. Overdose is rare but may cause nausea, vomiting, or gastrointestinal discomfort if large amounts are swallowed. Severe toxicity or serious systemic effects are uncommon, and the drug is considered safe for short-term use when taken as directed.